Kaori Yoshimura

Anti-tumor Activity of the Small Molecule Inhibitor PRI-724 Against β-Catenin-activated Hepatocellular Carcinoma

Ryosuke Gabata, Kenichi Harada, Yuki Mizutani et al. · Anticancer Research · 2020 · 39 citations · Full text

Medicine, Oncology, Pharmacology +14

Diversity in cell differentiation, histology, phenotype and vasculature of mass‐forming intrahepatic cholangiocarcinomas

Hiep Nguyen Canh, Kenta Takahashi, Minako Yamamura et al. · Histopathology · 2021 · 33 citations

Medicine, Oncology, Pathology +11

Case of metastatic glioblastoma with primitive neuronal component to the lung

Sho Tamai, Masashi Kinoshita, Hemragul Sabit et al. · Neuropathology · 2019 · 22 citations

Medicine, Neurosurgery, Oncology +15

A novel pathologic marker, indoleamine 2,3-dioxygenase 1, for the cholangiopathy of immune checkpoint inhibitors-induced immune mediated hepatotoxicity as adverse events and the prediction of additional ursodeoxycholic acid treatment

Kaori Yoshimura, Yuko Tamano, Hiep Nguyen Canh et al. · Medical Molecular Morphology · 2023 · 10 citations

Medicine, Pathology, Pharmacology +17